J Neurol Surg B Skull Base 2018; 79(06): 559-568
DOI: 10.1055/s-0038-1641752
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Incidence of Prolonged Systemic Steroid Treatment after Surgery for Acoustic Neuroma and Its Implications

Kenny F. Lin
1   Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States
,
Claire R. Stewart
1   Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States
,
Philip E. Steig
2   Department of Neurological Surgery, Weill Cornell Medical College, New York, United States
,
Cameron W. Brennan
3   Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, United States
,
Philip H. Gutin
3   Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, United States
,
Samuel H. Selesnick
1   Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States
› Author Affiliations
Disclosure of Funding None.
Further Information

Publication History

19 November 2017

02 March 2018

Publication Date:
13 April 2018 (online)

Abstract

Objectives To determine the incidence of prolonged postoperative systemic corticosteroid therapy after surgery for acoustic neuroma as well as the indications and associated risk factors that could lead to prolonged steroid administration, and the incidence of steroid-related adverse effects.

Study Designs Retrospective chart review.

Methods Retrospective chart review of patients undergoing resection of acoustic neuroma between 2010 and 2017 at two tertiary care medical centers. Patient and tumor characteristics, operative approach, hospital length of stay, initial postoperative taper length, number of discrete postoperative steroid courses, and postoperative complications were analyzed.

Results There were 220 patients (99 male, 121 female) with an average age of 49.4 (range 16–78). There were 124 left-sided tumors and 96 right-sided tumors. Within the group, 191 tumors were operated through a retrosigmoid approach, 25 tumors through a translabyrinthine approach, and 4 tumors with a combined retrosigmoid–translabyrinthine approach under the same anesthetic. In total, 35 (15.9%) patients received an extended initial course of postoperative systemic steroids, defined as a taper longer than 18 days. Twenty six (11.8%) patients received additional courses of systemic steroids after the initial postoperative taper. There were 5 (2.3%) patients who required an extended initial taper as well as additional courses of steroids. Aseptic meningitis, often manifested as headache, was the most common indication for additional steroids (14 cases of prolonged taper and 17 cases of additional courses). None of the patient or tumor factors including age, gender, side, size, and approach were statistically significantly associated with either a prolonged initial steroid taper or additional courses of steroids. An extended hospital length of stay was associated with a prolonged initial steroid taper (p = 0.03), though the initial taper length was not predictive of additional courses of steroids. The cumulative number of days on steroids was associated with need for additional procedures (p < 0.01) as well as steroid-related side effects (p = 0.05). The administration of steroids was not found to significantly improve outcomes in postoperative facial paresis. Steroid-related complications were uncommon, seen in 9.26% of patients receiving steroids, with the most common being psychiatric side effects such as agitation, anxiety, and mood lability.

Conclusions Systemic corticosteroids are routinely administered postoperatively for patients undergoing craniotomy for the resection of acoustic neuromas. In a review of 220 patients operated by a single neurotologist, no patient or tumor factors were predictive of requiring prolonged initial steroid taper or additional courses of steroids. The cumulative number of days on systemic steroids was associated with undergoing additional procedures and steroid-related side effects. The most common indications for prolonged or additional steroids were aseptic meningitis, cerebrospinal fluid leak, and facial paresis. Additional steroids for postoperative facial paresis did not significantly improve outcomes. Patient-reported steroid-related complications were infrequent and were most commonly psychiatric including agitation, anxiety, and mood lability.

 
  • References

  • 1 McClelland III S, Long DM. Genesis of the use of corticosteroids in the treatment and prevention of brain edema. Neurosurgery 2008; 62 (04) 965-967 , discussion 967–968
  • 2 Buchman CA, Fucci MJ, Slattery WH, Brackmann DE, Berliner KI. Intraoperative corticosteroids in acoustic tumor surgery. Am J Otol 1999; 20 (03) 386-389
  • 3 Gouveris H, Mewes T, Maurer J, Mann W. Steroid and vasoactive treatment for acute deafness after attempted hearing preservation acoustic neuroma surgery. ORL J Otorhinolaryngol Relat Spec 2005; 67 (01) 30-33
  • 4 Poetker DM, Reh DD. A comprehensive review of the adverse effects of systemic corticosteroids. Otolaryngol Clin North Am 2010; 43 (04) 753-768
  • 5 Schick B, Dlugaiczyk J. Surgery of the ear and the lateral skull base: pitfalls and complications. GMS Curr Top Otorhinolaryngol Head Neck Surg 2013; 12 (0i): Doc05
  • 6 Bowers CA, Gurgel RK, Brimley C. , et al. Surgical treatment of vestibular schwannoma: does age matter?. World Neurosurg 2016; 96: 58-65
  • 7 Olshan M, Srinivasan VM, Landrum T, Sataloff RT. Acoustic neuroma: An investigation of associations between tumor size and diagnostic delays, facial weakness, and surgical complications. Ear Nose Throat J 2014; 93 (08) 304-316
  • 8 Backes JR, Bentley JC, Politi JR, Chambers BT. Dexamethasone reduces length of hospitalization and improves postoperative pain and nausea after total joint arthroplasty: a prospective, randomized controlled trial. J Arthroplasty 2013; 28 (08) , Suppl): 11-17
  • 9 Hansen MS, Brennum J, Moltke FB, Dahl JB. Suboptimal pain treatment after craniotomy. Dan Med J 2013; 60 (02) A4569
  • 10 Apfel CC, Korttila K, Abdalla M. , et al; IMPACT Investigators. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 2004; 350 (24) 2441-2451
  • 11 Sanchez GB, Kaylie DM, O'Malley MR, Labadie RF, Jackson CG, Haynes DS. Chemical meningitis following cerebellopontine angle tumor surgery. Otolaryngol Head Neck Surg 2008; 138 (03) 368-373
  • 12 Zarrouk V, Vassor I, Bert F. , et al. Evaluation of the management of postoperative aseptic meningitis. Clin Infect Dis 2007; 44 (12) 1555-1559
  • 13 Sullivan FM, Swan IRC, Donnan PT. , et al. Early treatment with prednisolone or acyclovir in Bell's palsy. N Engl J Med 2007; 357 (16) 1598-1607
  • 14 Bozorg Grayeli A, Ferrary E, Tubach F. , et al. Effect of corticosteroids on facial function after cerebellopontine angle tumor removal: a double-blind study versus placebo. Audiol Neurootol 2015; 20 (04) 213-221
  • 15 Carlstrom LP, Copeland III WR, Neff BA, Castner ML, Driscoll CLW, Link MJ. Incidence and risk factors of delayed facial palsy after vestibular schwannoma resection. Neurosurgery 2016; 78 (02) 251-255
  • 16 Darrouzet V, Martel J, Enée V, Bébéar JP, Guérin J. Vestibular schwannoma surgery outcomes: our multidisciplinary experience in 400 cases over 17 years. Laryngoscope 2004; 114 (04) 681-688
  • 17 Mehendale NH, Samy RN, Roland PS. Management of pseudomeningocele following neurotologic procedures. Otolaryngol Head Neck Surg 2004; 131 (03) 253-262
  • 18 Reviews S, Dec NN, Stuck AE, Minder CE, Frey FJ. Risk of Infectious Complications in Patients Taking Glucocorticosteroids Author (s): Andreas E. Stuck, Christoph E. Minder and Felix J. Frey Published by : Oxford University Press Stable URL: http://www.jstor.org/stable/4455379 Risk of Infectious C. 2017 ;11(6):954–963
  • 19 Waljee AK, Rogers MAM, Lin P. , et al. Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. BMJ 2017; 357: j1415
  • 20 Broersen LH, Pereira AM, Jørgensen JO, Dekkers OM. Adrenal Insufficiency in corticosteroids use: systematic review and meta-analysis. J Clin Endocrinol Metab 2015; 100 (06) 2171-2180